HighMark Wealth Management LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 118 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is 1.21 and the average weighting 1.0%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$2,715
-24.9%
3970.0%0.00%0.0%
Q1 2024$3,613
+104.0%
3970.0%0.00%
+100.0%
Q4 2023$1,771
+42.0%
3970.0%0.00%0.0%
Q3 2023$1,247
-39.1%
3970.0%0.00%
-50.0%
Q2 2023$2,049
-2.1%
3970.0%0.00%0.0%
Q1 2023$2,092
+87.5%
3970.0%0.00%
+100.0%
Q4 2022$1,116
-44.2%
3970.0%0.00%
-50.0%
Q3 2022$2,0000.0%3970.0%0.00%0.0%
Q2 2022$2,0000.0%3970.0%0.00%
+100.0%
Q1 2022$2,000
-33.3%
3970.0%0.00%
-50.0%
Q4 2021$3,000
-25.0%
3970.0%0.00%
-33.3%
Q3 2021$4,000
-33.3%
3970.0%0.00%
-25.0%
Q2 2021$6,000
-14.3%
3970.0%0.00%
-33.3%
Q1 2021$7,000
-12.5%
3970.0%0.01%
-14.3%
Q4 2020$8,000
-55.6%
397
-83.4%
0.01%
-56.2%
Q3 2020$18,000
-10.0%
2,3970.0%0.02%
-27.3%
Q2 2020$20,000
+81.8%
2,3970.0%0.02%
+69.2%
Q1 2020$11,000
+22.2%
2,3970.0%0.01%
+30.0%
Q4 2019$9,0002,3970.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders